Objective Neuromyelitis optica (NMO) attacks often are severe, are difficult to treat, and
leave residual deficits. Here, we analyzed the frequency, sequence, and efficacy of …

Objective To analyze whether 1 of the 2 apheresis techniques, therapeutic plasma
exchange (PE) or immunoadsorption (IA), is superior in treating neuromyelitis optica …

Objective To analyse predictors for relapses and number of attacks under different
immunotherapies in patients with neuromyelitis optica spectrum disorder (NMOSD). Design …

Background: Gender and age at onset are important epidemiological factors influencing
prevalence, clinical presentation, and treatment response in autoimmune diseases …

Glatiramer acetate (GA) is an approved therapy for relapsing–remitting multiple sclerosis,
but its efficacy for the prevention of attacks in neuromyelitis optica spectrum disorder …

In current international classification systems (ICD-10, DSM5), the diagnostic criteria for
psychotic disorders (eg schizophrenia and schizoaffective disorder) are based on …

Abstract X-linked Adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene
resulting in the accumulation of very long chain fatty acids (VLCFA). X-ALD is the most …

Background: In 2009, we identified TACO1 as a novel mitochondrial disease gene in a
single family, however no second family has been described to confirm the role of TACO1 in …

Magnetic resonance imaging (MRI) findings in PLA2G6-associated Neurodegeneration
(PLAN), a “Neurodegeneration with Brain Iron Accumulation”(NBIA) disorder caused by …

Background People with complex symptomatology but unclear diagnosis presenting to a
centre for rare diseases (CRD) may present with mental (co-) morbidity. We hypothesised …